SCHEMBL26239774

SCHEMBL26239774

CCCCCc1ccc(CCC(=O)OC)cc1CCCCC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.50
ALDH1A1 P00352 1/20 0.50
KMT2A Q03164 1/20 0.50
CYP1A2 P05177 2/20 0.45
CYP3A4 P08684 2/20 0.45
CYP2C8 P10632 2/20 0.45
CYP2C9 P11712 2/20 0.45
CYP2B6 P20813 2/20 0.45
CYP2C19 P33261 2/20 0.45
PPARA Q07869 2/20 0.45
PPARG P37231 1/20 0.45
LTA4H P09960 2/20 0.42
IAPP P10997 1/20 0.42
CYP2E1 P05181 1/20 0.41
HTR1A P08908 1/20 0.41
ALOX5 P09917 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2A6 P11509 1/20 0.41
TRPV1 Q8NER1 1/20 0.41
KAT8 Q9H7Z6 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26239792 0.99 MEN1 (0.52) MEN1ALDH1A1KMT2ACYP1A2CYP3A4
SCHEMBL20429081 0.88 PTPN1 (0.46) ALDH1A1KMT2ACYP1A2CYP3A4ALOX5
SCHEMBL26239722 0.85 ALDH1A1 (0.53) MEN1ALDH1A1KMT2ACYP3A4PPARA
SCHEMBL26239742 0.85 ALDH1A1 (0.53) MEN1ALDH1A1KMT2ACYP3A4PPARA
SCHEMBL26239854 0.84 ALDH1A1 (0.56) ALDH1A1CYP3A4
SCHEMBL27594037 0.84 IAPP (0.51) MEN1KMT2ACYP1A2CYP3A4CYP2C8
SCHEMBL12737898 0.83 MEN1 (0.52) MEN1ALDH1A1KMT2ACYP3A4PPARA
SCHEMBL27357681 0.83 FAAH (0.55) MEN1ALDH1A1KMT2ACYP3A4
SCHEMBL26239880 0.83 FAAH (0.55) MEN1ALDH1A1KMT2ACYP3A4
SCHEMBL26239763 0.82 CYP4F2 (0.50) MEN1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024098361-A1 ARTIFICIAL NUCLEIC ACID MOLECULE 斯微(上海)生物科技股份有限公司 2024-05-16 WO disclosed
US-20230263742-A1 A LIPID Stemirna Therapeutics Co., Ltd. (CN) 2023-08-24 US disclosed
US-20230263742-A1 A LIPID Stemirna Therapeutics Co., Ltd. (CN) 2023-08-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230263742-A1 A LIPID CETP, PLIN1, AUP1 MEN1 1924/4885ALDH1A1 1643/4885KMT2A 2115/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.